Sanjivani Paranteral touches roof on inking pact with Hindustan Antibiotics
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sanjivani Paranteral is currently trading at its upper limit of Rs. 76.65, up by 3.65 points or 5.00% from its previous closing of Rs. 73.00 on the BSE.
The scrip opened at Rs. 73.65 and has touched a high and low of Rs. 76.65 and Rs. 73.65 respectively. So far 31450 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 76.65 on 02-Aug-2023 and a 52 week low of Rs. 24.80 on 24-Mar-2023.
Last one week high and low of the scrip stood at Rs. 76.65 and Rs. 66.99 respectively. The current market cap of the company is Rs. 76.64 crore.
The promoters holding in the company stood at 31.70%, while Institutions and Non-Institutions held 11.89% and 56.41% respectively.
Sanjivani Paranteral has signed an agreement with M/s Hindustan Antibiotics for the manufacturing of IV formulations and IV Sets. The agreement is backed by confirmed purchase commitment from M/s Hindustan Antibiotics. The plant will be set-up in the premises of M/s Hindustan Antibiotics, Pimpri works, Pune, Maharashtra.
Sanjivani Paranteral is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices.
